Daniel E. Ryweck - 23 May 2025 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: Chief Financial Officer
Signature: /s/ Daniel E. Ryweck
Issuer symbol: SILO
Transactions as of: 23 May 2025
Net transactions value: $0
Form type: 4
Filing time: 27 May 2025, 19:02:50 UTC
Previous filing: 26 May 2023
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ryweck Daniel E.	Chief Financial Officer	C/O SILO PHARMA, INC., 677 N. WASHINGTON BOULEVARD, SARASOTA	/s/ Daniel E. Ryweck	27 May 2025	0001652799

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILO	Options (right to buy)	Award	$0	+50,000	+1000%	$0.000000	55,000	23 May 2025	Common Stock	50,000	$0.4290	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant.